학술논문
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
Document Type
Article
Author
Source
In Neurotherapeutics January 2022 19(1):325-333
Subject
Language
ISSN
1878-7479